Recent research has shown that chronic inflammation caused by activation of the human immune system contributes to a large and rapidly growing list of diseases.
Significant advances in understanding the role that the cytokine-mediated JAK/STAT signaling network and pattern recognition receptors (PRRs) play in regulating immune responses and their potential as novel targets for developing potent new therapies are presented in a Review article in Journal of Interferon & Cytokine Research
(JICR) from Mary Ann Liebert, Inc publishers. The article is available free on the Journal of Interferon & Cytokine Research website until November 15, 2014.
Brendan John Jenkins, MIMR-PHI Institute of Medical Research (Clayton, Victoria, Australia), reviews the latest research and highlights key findings that help explain how cross-talk between cell signaling networks mediated by cytokines and PRRs can impact the development of a variety of disease processes. The authors describe the potential therapeutic implications of targeting these critical networks in the article "Transcriptional Regulation of Pattern Recognition Receptors by JAK/STAT Signaling, and the Implications for Disease Pathogenesis."
"Dr. Jenkins provides an important new perspective on the role of pattern recognition receptors in disease pathogenesis," says JICR Co-Editor-in-Chief Thomas A. Hamilton, PhD, Chairman, Department of Immunology, Cleveland Clinic Foundation, Ohio.